middle.news
How Inhalerx’s $51M Funding Secures Its Clinical Trial Future
1:34pm on Thursday 29th of January, 2026 AEDT
•
Healthcare
Read Story
How Inhalerx’s $51M Funding Secures Its Clinical Trial Future
1:34pm on Thursday 29th of January, 2026 AEDT
Key Points
Net operating cash outflow of $628K for the quarter
Drawdown of $405K from $38.5M Linlithgow Family Office funding facility
New $12.6M facility secured for SRX-25 clinical trials, undrawn as of quarter-end
Cash and equivalents at $436K with $50.8M in unused financing facilities
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
INHALERX (ASX:IRX)
OPEN ARTICLE